Blood Products Market: By Type (Whole Blood, Blood Components, Blood Derivatives), By Product (Packed RBCs, Platelets, FFP, Cryo, Washed Red Blood Cells, Irradiated Blood) By Application (Treatment, Diagnosis), By End User (Blood Banks, Diagnostic Centres, Hospitals), By Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Blood Products Market size was valued at USD 35506 million in 2022 and is poised to grow at a CAGR of 4.4% from 2023 - 2029. has plentiful of market players and it is consolidated. In terms of processing devices, strong market players are present. Companies in this market are focusing on new product developments and market expansions for strengthen their market share. These are classified blood components arranged in the blood transfusion focus (red cells, platelets, crisp solidified plasma and cryoprecipitate) or plasma subsidiaries produced from pooled plasma gifts in plasma fractionation focuses, (for example, egg whites, coagulation components and immunoglobulins). Furthermore companies are also strengthening their position by acquiring the other companies operating in same market. 

 Blood Products Market Key Developments: 
  • In August 2012, Haemonetics Corporation acquired business assets of blood collection, filteration and processing product lines of Pall Corpration.
  • On November 11, 2013, Grifols, a global healthcare company and producer of plasma therapies, acquired the transfusion diagnostics unit of Novartis. Furthermore, government organizations and non-government organizations are also playing major role in providing awareness regarding life threatening diseases, blood transfusion, blood donation etc.

Blood Products Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

4.4%

Largest Market

North America

Fastest Growing Market

Asia Pacific
 Blood Products Market Dynamics

Increase in the prevalance of various diseases, expanded need of blood during several surgical procedurs, increse in government initiatives regarding necessity of blood donation, safety of blood transfusion, several blood donating campaigns are some of the factors that are fuelling the growth of the blood products market. However, Lack of awareness and lack of skilled and trained professionals can lead to misleading transfusion thus, declining the sales of blood products globally.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Blood Products Market Segmentation

By Type
  • Whole Blood
  • Blood Components
  • Blood Derivatives
By Product
  • Packed RBCs
  • Platelets
  • FFP
  • Cryo
  • Washed Red Blood Cells
  • Irradiated Blood
By Application
  • Treatment
  • Diagnosis
By End User
  • Blood Banks
  • Diagnostic Centres
  • Hospitals

Frequently Asked Questions

The blood products market size was valued at USD 35506 million in 2022

The blood products market key players are: Grifols (Spain) Medtronic (US) Becton, Dickinson and Company (US) Fresenius (Germany) Terumo (Japan) Haemonetics (US) Kawasumi Laboratories (Japan) Nipro Medical (US) Greiner Holding (Austria)

The blood products market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

1. Executive Summary
2. Global Blood Products Market Introduction 
2.1.Global Blood Products Market  - Taxonomy
2.2.Global Blood Products Market  - Definitions
2.2.1. Type 
2.2.2.Product
2.2.3.Application
2.2.4.End User
2.2.5.Region
3.Global Blood Products Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Blood Products Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Blood Products Market  By  Type , 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Whole Blood
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Blood Components
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Blood Derivatives
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6. Global Blood Products Market  By Product, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Packed RBCs
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Platelets
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. FFP
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Cryo
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Washed Red Blood Cells
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Irradiated Blood
6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
7. Global Blood Products Market  By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Treatment
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Diagnosis
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
8. Global Blood Products Market  By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. Blood Banks
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Diagnostic Centres
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Hospitals
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
9. Global Blood Products Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10. North America Blood Products Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1.  Type  Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Whole Blood
10.1.2.Blood Components
10.1.3.Blood Derivatives
10.2.  Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Packed RBCs
10.2.2.Platelets
10.2.3.FFP
10.2.4.Cryo
10.2.5.Washed Red Blood Cells
10.2.6.Irradiated Blood
10.3.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Treatment
10.3.2.Diagnosis
10.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Blood Banks
10.4.2.Diagnostic Centres
10.4.3.Hospitals
10.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11. Europe Blood Products Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1.  Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Whole Blood
11.1.2.Blood Components
11.1.3.Blood Derivatives
11.2.  Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Packed RBCs
11.2.2.Platelets
11.2.3.FFP
11.2.4.Cryo
11.2.5.Washed Red Blood Cells
11.2.6.Irradiated Blood
11.3.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Treatment
11.3.2.Diagnosis
11.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Blood Banks
11.4.2.Diagnostic Centres
11.4.3.Hospitals
11.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12. Asia Pacific (APAC) Blood Products Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1.  Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Whole Blood
12.1.2.Blood Components
12.1.3.Blood Derivatives
12.2.  Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Packed RBCs
12.2.2.Platelets
12.2.3.FFP
12.2.4.Cryo
12.2.5.Washed Red Blood Cells
12.2.6.Irradiated Blood
12.3.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Treatment
12.3.2.Diagnosis
12.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Blood Banks
12.4.2.Diagnostic Centres
12.4.3.Hospitals
12.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13. Middle East and Africa (MEA) Blood Products Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1.  Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Whole Blood
13.1.2.Blood Components
13.1.3.Blood Derivatives
13.2.  Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Packed RBCs
13.2.2.Platelets
13.2.3.FFP
13.2.4.Cryo
13.2.5.Washed Red Blood Cells
13.2.6.Irradiated Blood
13.3.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Treatment
13.3.2.Diagnosis
13.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Blood Banks
13.4.2.Diagnostic Centres
13.4.3.Hospitals
13.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14. Latin America Blood Products Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
14.1.  Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Whole Blood
14.1.2.Blood Components
14.1.3.Blood Derivatives
14.2.  Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Packed RBCs
14.2.2.Platelets
14.2.3.FFP
14.2.4.Cryo
14.2.5.Washed Red Blood Cells
14.2.6.Irradiated Blood
14.3.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Treatment
14.3.2.Diagnosis
14.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Blood Banks
14.4.2.Diagnostic Centres
14.4.3.Hospitals
14.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Grifols (Spain)
15.2.2.Medtronic (US)
15.2.3.Becton, Dickinson and Company (US)
15.2.4.Fresenius (Germany)
15.2.5.Terumo (Japan)
15.2.6.Haemonetics (US)
15.2.7.Kawasumi Laboratories (Japan)
15.2.8.Nipro Medical (US)
15.2.9.Greiner Holding (Austria)
16. Research Methodology 
17. Appendix and Abbreviations 
  • Grifols (Spain)
  • Medtronic (US)
  • Becton, Dickinson and Company (US)
  • Fresenius (Germany)
  • Terumo (Japan)
  • Haemonetics (US)
  • Kawasumi Laboratories (Japan)
  • Nipro Medical (US)
  • Greiner Holding (Austria)

Adjacent Markets